Trial Identifier: | D5084C00009 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04606771 |
Start Date: | September 2020 |
Primary Completion Date: | December 2022 |
Study Completion Date: | December 2024 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English Version | |
Spanish (Argentina) Translation | |
Hindi Translation | |
Thai Translation | |
Vietnamese Translation | |
Taiwan (Traditional Chinese) Translation |
Country | Location |
---|---|
AR | Buenos Aires, AR, C1120AAT |
IN | Delhi, IN, 110085 |
IN | Mumbai, IN, 400053 |
TH | Bangkok, TH, 10330 |
TH | Bangkok, TH, 10400 |
TH | Bangkok, TH, 10700 |
TH | Bangkok, TH, 10300 |
TH | Bangkok, TH, 10210 |
TH | Hat Yai, TH, 90110 |
TH | Khon Kaen, TH, 40002 |
TH | Muang, TH, 50200 |
TW | Taichung City, TW, 402 |
TW | Taipei, TW, 235 |
TW | Taipei, TW, 11217 |
TW | Taipei, TW, 100 |
TW | Taoyuan City, TW, 333 |
US, CA | Duarte, CA, US, 91010 |
US, CA | Sacramento, CA, US, 95817 |
VN | Ha Noi, VN, 100000 |
VN | Hanoi, VN, 100000 |
VN | Ho Chi Minh city, VN, 700000 |